Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.

Saved in:
Bibliographic Details
Title: Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals.
Authors: Wang E; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. EWang40@jhmi.edu., Mathai DS; Sattva Medicine Psychiatry/Psychotherapy Practice, Miami, FL, USA.; Ethical Legal Implications of Psychedelics in Society Program, Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA., Gukasyan N; Department of Psychiatry, Columbia University Medical Center, New York State Psychiatric Institute, New York, NY, USA., Nayak S; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Garcia-Romeu A; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. AGarci33@jhmi.edu.; Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA. AGarci33@jhmi.edu.
Source: Scientific reports [Sci Rep] 2024 Nov 14; Vol. 14 (1), pp. 28022. Date of Electronic Publication: 2024 Nov 14.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2045-2322
DOI:10.1038/s41598-024-78736-1